PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers design global HIV vaccine that shows promise in monkeys

Preclinical study provides strong rationale for clinical trials

2013-10-24
(Press-News.org) Contact information: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Researchers design global HIV vaccine that shows promise in monkeys Preclinical study provides strong rationale for clinical trials BOSTON -- The considerable diversity of HIV worldwide represents a critical challenge for designing an effective HIV vaccine. Now, a scientific team led by Beth Israel Deaconess Medical Center (BIDMC) has shown that bioinformatically optimized HIV vaccine antigens known as "mosaic" antigens might be useful in the design of a global HIV vaccine. This study, which was conducted in monkeys, is published today in the journal Cell.

"A global HIV vaccine would offer major biomedical and practical advantages over most other HIV vaccine candidates, which are limited to certain regions of the world," says lead author Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, Director of the Vaccine Program at the Ragon Institute of MGH, MIT and Harvard, and Professor of Medicine at Harvard Medical School. "To our knowledge, this study represents the first evaluation of the protective efficacy of a candidate global HIV antigen strategy in nonhuman primates."

In this new publication, the authors demonstrate for the first time that mosaic HIV vaccine antigens can afford partial protection in rhesus monkeys against challenges with a stringent simian-human immunodeficiency virus. These mosaic vaccine antigens have been developed for optimal immunologic coverage of global HIV diversity.

Barouch and his team studied the immunogenicity of HIV mosaic Env/Gag/Pol antigens administered to monkeys using viral vectors. Env, Gag, and Pol are three major HIV proteins. After immunization, the monkeys were repetitively exposed to multiple simian-human immunodeficiency virus challenges and the investigators evaluated the ability of the vaccines to block infection.

Although most animals immunized with the mosaic HIV vaccine became infected by the end of the study, the researchers observed an 87 to 90 percent reduction in monkeys' probability of becoming infected each time they were exposed to the virus. In contrast, monkeys that received sham vaccines became infected more quickly.

"These findings indicate that these optimized vaccine antigens can afford partial protection in a stringent animal model," says Barouch.

The investigators found that the immunized monkeys mounted antibody responses against diverse strains of HIV noting, "Protection was dependent on several different types of antibody responses, suggesting that the coordinated activity of multiple antibody functions may contribute to protection against difficult-to-neutralize viruses." The monkeys also mounted cellular immune responses to multiple regions of the virus.

The researchers note that most previous HIV vaccine candidates have typically only been testedin monkeys for protection against easy-to-neutralize viruses rather than against a difficult-to-neutralize virus like the one used in this study. Also, each viral challenge in the study was approximately 100-fold more infectious than typical sexual HIV exposures in humans.

"These data suggest a path forward for the development of a global HIV vaccine and give us hope that such a vaccine might indeed be possible," said Barouch. "We are planning to advance this HIV vaccine candidate into clinical trials next year," he adds.

### The vaccine regimen tested in the study has two components: The two Ad vaccines are based on the AdVac platform developed by Crucell Holland BV, one of the Janssen Pharmaceutical Companies of Johnson and Johnson, in collaboration with BIDMC. The MVA vaccine was developed by U.S. Military HIV Research Program (MHRP) scientists in collaboration with the National Institutes of Allergy and Infectious Diseases (NIAID) Laboratory of Viral Diseases.

Study coauthors include BIDMC investigators Kathryn E. Stephenson, Erica N. Borducchi, Kaitlin Smith, Kelly Stanley, Anna G. McNally, Jinyan Liu, Peter Abbink, Lori F. Maxfield, and Michael S. Seaman. Other coauthors are from the U.S. Military HIV Research Program (MHRP), the Los Alamos National Laboratory, Crucell Holland BV, and the Laboratory of Viral Diseases at the NIAID.

Support for this work was provided by the U.S. Military Research and Material Command and the U.S. Military HIV Research Program (W81XWH-07-2-0067); the National Institutes of Health (AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, and AI00645); the NIAID Division of Intramural Research; the Ragon Institute of MGH, MIT, and Harvard; and the Bill and Melinda Gates Foundation.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

BIDMC has a network of community partners that includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.


ELSE PRESS RELEASES FROM THIS DATE:

Genetic mutation provides clues to battling childhood obesity

2013-10-24
Genetic mutation provides clues to battling childhood obesity As the number of children battling obesity continues to grow, researchers are racing to identify causes and possible interventions. Now, a new paper publishing October 24 in the journal Cell identifies a possible ...

Bee sting allergy could be a defense response gone haywire, Stanford scientists say

2013-10-24
Bee sting allergy could be a defense response gone haywire, Stanford scientists say STANFORD, Calif. — For most people, a bee sting causes temporary pain and discomfort, but for those with a bee venom allergy, the consequences can be devastating: ...

Researchers identify gene variant that raises risk for colorectal cancer from eating processed meat

2013-10-24
Researchers identify gene variant that raises risk for colorectal cancer from eating processed meat Discovery sets first step towards identification of genetic variants linked to carcinogenic risk from diet and nutrition A common genetic variant that affects ...

Reservoir of hidden HIV larger than previously thought

2013-10-24
Reservoir of hidden HIV larger than previously thought New findings put spotlight on need for new drugs to target HIV proviruses In the fight to cure human immunodeficiency virus (HIV), researchers have been dealt a blow. A new study by Howard Hughes Medical Institute ...

Researchers apply brainpower to understanding neural stem cell differentiation

2013-10-24
Researchers apply brainpower to understanding neural stem cell differentiation How do humans and other mammals get so brainy? USC researcher Wange Lu, PhD, and his colleagues shed new light on this question in a paper that will be published in Cell ...

Novel genetic mutations cause low metabolic rate and obesity

2013-10-24
Novel genetic mutations cause low metabolic rate and obesity Researchers believe the gene could be a useful therapeutic target for treating obesity and type 2 diabetes Researchers from the University of Cambridge have discovered a novel genetic cause of severe ...

For fish and rice to thrive in Yolo Bypass, 'just add water'

2013-10-24
For fish and rice to thrive in Yolo Bypass, 'just add water' From a fish-eye view, rice fields in California's Yolo Bypass provide an all-you-can-eat bug buffet for juvenile salmon seeking nourishment on their journey to the sea. That's according ...

Physicists decode decision circuit of cancer metastasis

2013-10-24
Physicists decode decision circuit of cancer metastasis Rice U. research reveals 3-way genetic switch for cancer metastasis Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and ...

Study shows no increased risk for heart attacks among HIV-positive patients with high CD4 cell count

2013-10-24
Study shows no increased risk for heart attacks among HIV-positive patients with high CD4 cell count Healthy HIV-positive subjects have same heart-attack risk as general population OAKLAND, Calif., October 24, 2013 — Patients who are HIV-positive and have high CD4 cell ...

Climate change and coevolution: We've done the math

2013-10-24
Climate change and coevolution: We've done the math A rule of thumb to help calculate the likely effect of climate change where species interact When scientists attempt to understand how climate change might reshape our environment, they must grapple ...

LAST 30 PRESS RELEASES:

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

Creativity across disciplines

Consequences of low Antarctic sea ice

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

[Press-News.org] Researchers design global HIV vaccine that shows promise in monkeys
Preclinical study provides strong rationale for clinical trials